StockData
IDEXX Laboratories Inc logo

IDEXX Laboratories Inc (IDXX) stock

IDXXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 19/3036% above fair value
$698.47+8.23 (+1.19%)

Close on Nov 18, 2026Market cap $55.03BP/E 49.1Yield –

IDEXX Laboratories total assets

Total assets on the balance sheet at the end of each period.

IDEXX Laboratories's total assets was $3.44B at Jun 30, 2026. For fiscal 2025 it was $3.35B, up 1.7% from the year before. Over ten years it grew 8.6% a year on average. The highest annual figure on record is $3.35B in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.35B+1.7%
FY2024Dec 31, 2024$3.29B+1.0%
FY2023Dec 31, 2023$3.26B+18.7%
FY2022Dec 31, 2022$2.75B+12.7%
FY2021Dec 31, 2021$2.44B+6.2%
FY2020Dec 31, 2020$2.29B+25.2%
FY2019Dec 31, 2019$1.83B+19.2%
FY2018Dec 31, 2018$1.54B-10.3%
FY2017Dec 31, 2017$1.71B+11.9%
FY2016Dec 31, 2016$1.53B+3.8%
FY2015Dec 31, 2015$1.47B+6.6%
FY2014Dec 31, 2014$1.38B+12.5%
FY2013Dec 31, 2013$1.23B+11.5%
FY2012Dec 31, 2012$1.10B+7.1%
FY2011Dec 31, 2011$1.03B+14.9%
FY2010Dec 31, 2010$897.14M+11.0%
FY2009Dec 31, 2009$808.53M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$3.44B+3.3%
Q1 FY2026Mar 31, 2026$3.39B+5.3%
Q4 FY2025Dec 31, 2025$3.35B+1.7%
Q3 FY2025Sep 30, 2025$3.39B+1.1%
Q2 FY2025Jun 30, 2025$3.33B-2.5%
Q1 FY2025Mar 31, 2025$3.21B-4.2%
Q4 FY2024Dec 31, 2024$3.29B+1.0%
Q3 FY2024Sep 30, 2024$3.35B+8.6%
Q2 FY2024Jun 30, 2024$3.41B+19.0%
Q1 FY2024Mar 31, 2024$3.35B+19.4%
Q4 FY2023Dec 31, 2023$3.26B+18.7%
Q3 FY2023Sep 30, 2023$3.09B+16.9%
Q2 FY2023Jun 30, 2023$2.87B+10.1%
Q1 FY2023Mar 31, 2023$2.81B+8.3%
Q4 FY2022Dec 31, 2022$2.75B+12.7%
Q3 FY2022Sep 30, 2022$2.64B+10.7%
Q2 FY2022Jun 30, 2022$2.61B+8.1%
Q1 FY2022Mar 31, 2022$2.59B+11.4%
Q4 FY2021Dec 31, 2021$2.44B+6.2%
Q3 FY2021Sep 30, 2021$2.39B+16.5%
Q2 FY2021Jun 30, 2021$2.41B+23.0%
Q1 FY2021Mar 31, 2021$2.33B+23.4%
Q4 FY2020Dec 31, 2020$2.29B+25.2%
Q3 FY2020Sep 30, 2020$2.05B+16.9%
Q2 FY2020Jun 30, 2020$1.96B+13.7%
Q1 FY2020Mar 31, 2020$1.89B+12.2%
Q4 FY2019Dec 31, 2019$1.83B+19.2%
Q3 FY2019Sep 30, 2019$1.75B+13.4%
Q2 FY2019Jun 30, 2019$1.72B+13.4%
Q1 FY2019Mar 31, 2019$1.68B+14.4%
Q4 FY2018Dec 31, 2018$1.54B-10.3%
Q3 FY2018Sep 30, 2018$1.54B-7.5%
Q2 FY2018Jun 30, 2018$1.52B-7.1%
Q1 FY2018Mar 31, 2018$1.47B-6.5%
Q4 FY2017Dec 31, 2017$1.71B+11.9%
Q3 FY2017Sep 30, 2017$1.67B+11.3%
Q2 FY2017Jun 30, 2017$1.64B–
Q1 FY2017Mar 31, 2017$1.57B–
Q4 FY2016Dec 31, 2016$1.53B–
Q3 FY2016Sep 30, 2016$1.50B–

More IDEXX Laboratories figures

See a number that looks wrong?